Aminocaproic acid NDC 72205-286

NDC codes

FDA NDC Directory

Product NDC (as listed)72205-286Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72205-0286Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72205-286-30	72205028630	30 TABLET in 1 BOTTLE (72205-286-30)Marketed from Sep 21, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aminocaproic acid
Generic name (nonproprietary): aminocaproic acid
Active ingredients: Aminocaproic acid — 1000 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Novadoz Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212938
Marketing start: Sep 13, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Fibrinolysis (Physiologic effect)
Identifiers: Product ID 72205-286_9d58cbb6-d3e8-4b56-a3f5-d2619db3b618SPL ID 9d58cbb6-d3e8-4b56-a3f5-d2619db3b618SPL set ID c5dc0c33-a0f9-43c4-9f10-3668f4361b87RxCUI 197351, 476271UNII U6F3787206UPC 0372205049307, 0372205286306
Pharmacologic class: Antifibrinolytic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472205028630 followed by a unit qualifier and the quantity

Package 72205-0286-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 6, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Aminocaproic acid tablets, USP is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. In life-threatening situations, transfusion of appropriate blood products and other emergency measures may be required. Fibrinolytic bleeding may frequently be associated with surgical complications following heart surgery (with or without cardiac bypass procedures) and portacaval shunt; hematological disorders such as amegakaryocytic thrombocytopenia (accompanying aplastic anemia); acute and life-threatening abruptio placentae; hepatic cirrhosis; and neoplastic disease such as carcinoma of the prostate, lung, stomach, and cervix. Urinary fibrinolysis, usually a n…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212938

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212938
Product	Strength	Form · route	Labeler	Product NDC
Aminocaproic acid	Aminocaproic acid 500 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-049